The effect of recombinant human erythropoietin (EPO) upon quality of life (QL) and functional capacity (FC) of anemic patients on chronic hemodialysis

Authors
Category Primary study
Year 1989
This article has no abstract
Epistemonikos ID: 7ce6557d6795bc9279d3e601980b0e7986cc4217
First added on: Oct 22, 2018